Evidence map›Paper›PMID 29167776›Full record

ArticleIranian journal of public health2017

Prognosis and Early Diagnosis of Ductal and Lobular Type in Breast Cancer Patient.

Houriyeh Ehtemam, Mitra Montazeri, Reza Khajouei, Raziyeh Hosseini, Ali Nemati, Vahid Maazed

Abstract read
In one paragraph

Article in Iranian journal of public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Houriyeh EhtemamHealth Services Management Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Mitra MontazeriModeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Reza KhajoueiMedical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Raziyeh HosseiniHealth Information Sciences Dept., Faculty of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Ali NematiHematology and Oncology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.
Vahid MaazedHematology and Oncology, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer is one of the most common cancers with a high mortality rate among women. Prognosis and early diagnosis of breast cancer among women society reduce considerable rate of their mortality. Nowadays, due to this illness, try to be setting up intelligent systems, which can predict and early diagnose this cancer, and reduce mortality of women society.

methodsOverall, 208 samples were collected from 2014 to 2015 from two oncologist offices and Javadalaemeh Clinic in Kerman, southeastern Iran. Data source was medical records of patients, then 64 data mining models in MATLAB and WEKA software were used, eventually these measured precision and accuracy of data mining models.

resultsAmong 64 data mining models, Bayes-Net model had 95.67% of accuracy and 95.70% of precision; therefore, was introduced as the best model for prognosis and diagnosis of breast cancer.

conclusionIntelligent and reliable data mining models are proposed. Hence, these models are recommended as a useful tool for breast cancer prediction as well as medical decision-making.

Indexed as

Breast cancerData mining modelsDiagnosisDuctal and lobular

Identifiers

PMID29167776
PMCPMC5696697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.